Skip to content

Evaluation of treatment with orthodontic aligners during different periods of use

Evaluation of the effectiveness of orthodontic treatment with clear aligners in different wear time protocols: randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6scsrgp
Enrollment
Unknown
Registered
2024-10-22
Start date
2024-04-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malocclusion

Interventions

This is a two-arm randomized controlled clinical study. Group 1 - control: 15 patients will wear Invisalign orthodontic aligners for a period of 22 hours a day. Group 2 - evaluation: 15 patients will

Sponsors

Faculdade de Odontologia de Bauru da Universidade de São Paulo
Lead Sponsor
Faculdade de Odontologia de Bauru da Universidade de São Paulo
Collaborator

Eligibility

Age
14 Years to 60 Years

Inclusion criteria

Inclusion criteria: Participants aged between 14 and 60; both sexes; complete permanent dentition; Angle Class I; good periodontal health; mild to moderate malloclusion

Exclusion criteria

Exclusion criteria: Patients with incisive agenesis; dental losses (except third molars); or indication of premolar extraction for orthodontic purposes

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of different daily protocols for the use of aligners, 10 hours and 22 hours, by assessing the dissolution of the patients' dental crowding in each of these periods, based on a variation of less than 5% post-intervention

Secondary

MeasureTime frame
To assess the durability of 2 fluid resins (conventional and with load) in the manufacture of attachments by evaluating their resistance during treatment, seeking a variation of less than 5% post-intervention

Countries

Brazil

Contacts

Public ContactCássia Rubira

Faculdade de Odontologia de Bauru da Universidade de São Paulo

rubira@fob.usp.br+55(14)3235-8356

Outcome results

None listed

Source: REBEC (via WHO ICTRP)